94 related articles for article (PubMed ID: 21849626)
1. The translational efficacy of a nonsteroidal progesterone receptor antagonist, 4-[3-cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on endometrial growth in macaque and human.
Howe DC; Mount NM; Bess K; Brown A; Bungay P; Gibson KR; Hawcock T; Richard J; Jones G; Walley R; McLeod A; Apfeldorfer C; Ramsey S; Tweedy S; Pullen N
J Pharmacol Exp Ther; 2011 Nov; 339(2):642-53. PubMed ID: 21849626
[TBL] [Abstract][Full Text] [Related]
2. The translational pharmacology of a novel, potent, and selective nonsteroidal progesterone receptor antagonist, 2-[4-(4-cyano-phenoxy)-3,5-dicyclopropyl-1H-pyrazol-1-yl]-N-methylacetamide (PF-02367982).
de Giorgio-Miller A; Bungay P; Tutt M; Owen J; Goodwin D; Pullen N
J Pharmacol Exp Ther; 2008 Oct; 327(1):78-87. PubMed ID: 18593954
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and clinical pharmacokinetics of PF-02413873, a nonsteroidal progesterone receptor antagonist.
Bungay PJ; Tweedy S; Howe DC; Gibson KR; Jones HM; Mount NM
Drug Metab Dispos; 2011 Aug; 39(8):1396-405. PubMed ID: 21543556
[TBL] [Abstract][Full Text] [Related]
4. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
[TBL] [Abstract][Full Text] [Related]
5. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
7. [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].
Jiang J; Wu R; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):218-21. PubMed ID: 11783365
[TBL] [Abstract][Full Text] [Related]
8. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
Murphy AA; Castellano PZ
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of progesterone receptor modulators and their effect on the endometrium.
Spitz IM
Curr Opin Obstet Gynecol; 2009 Aug; 21(4):318-24. PubMed ID: 19602929
[TBL] [Abstract][Full Text] [Related]
10. Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model.
Slayden OD; Zelinski MB; Chwalisz K; Hess-Stumpp H; Brenner RM
Hum Reprod; 2006 Dec; 21(12):3081-90. PubMed ID: 16936297
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor antagonists and the endometrial antiproliferative effect.
Brenner RM; Slayden OD
Semin Reprod Med; 2005 Feb; 23(1):74-81. PubMed ID: 15714391
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal progesterone receptor modulators: structure activity relationships.
Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
[TBL] [Abstract][Full Text] [Related]
13. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor antagonists.
Spitz IM
Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
[TBL] [Abstract][Full Text] [Related]
15. New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.
Cabeza M; García-Lorenzana M; Garcés M; Heuze I; Teran N; Bratoeff E
Steroids; 2010 Jan; 75(1):101-8. PubMed ID: 19913568
[TBL] [Abstract][Full Text] [Related]
16. Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies.
Gopalkrishnan K; Katkam RR; Sachdeva G; Kholkute SD; Padwal V; Puri CP
Biol Reprod; 2003 Jun; 68(6):1959-67. PubMed ID: 12606448
[TBL] [Abstract][Full Text] [Related]
17. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms.
Attardi B; Scott R; Pfaff D; Fink G
J Neuroendocrinol; 2007 Dec; 19(12):988-1000. PubMed ID: 18001329
[TBL] [Abstract][Full Text] [Related]
18. The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression.
Gordon A; Garrido-Gracia JC; Aguilar R; Bellido C; Velasco JA; Millan Y; Tena-Sempere M; Martín de Las Mulas J; Sánchez-Criado JE
J Endocrinol; 2008 Mar; 196(3):583-92. PubMed ID: 18310454
[TBL] [Abstract][Full Text] [Related]
19. Nongenomic inhibition of oxytocin binding by progesterone in the ovine uterus.
Dunlap KA; Stormshak F
Biol Reprod; 2004 Jan; 70(1):65-9. PubMed ID: 12954727
[TBL] [Abstract][Full Text] [Related]
20. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
